Late peripheral stent thrombosis due to stent fracture, vigorous exercise and hyporesponsiveness to clopidogrel;Späte periphere Stentthrombose bei Stentfraktur, starker körperlicher Belastung und Clopidogrel-Non-Response

Vasa - Journal of Vascular Diseases

Volumn 41, Issue 2, 2012, Pages 136-144

  Linnemann, Birgit ^a   Thalhammer, Axel ^a   Wolf, Zsuzsanna ^a   Tirneci, Vanessa ^a   Vogl, Thomas J ^a   Lindhoff Last, Edelgard ^a  

^a UNIVERSITY HOSPITAL FRANKFURT   (Germany)

Author keywords

Clopidogrel; Exercise; Hyporesponsiveness; Late stent thrombosis; Stent fracture; Superficial femoral artery

Indexed keywords

ACETYLSALICYLIC ACID; ALTEPLASE; CLOPIDOGREL;

AGED; ARTICLE; BLOOD CLOT LYSIS; CASE REPORT; COMBINATION CHEMOTHERAPY; CORONARY ARTERY DISEASE; DRUG RESPONSE; EXERCISE; HUMAN; HYPERCHOLESTEROLEMIA; HYPERTENSION; INTERMITTENT CLAUDICATION; MALE; MINIMAL RESIDUAL DISEASE; PROSTHESIS FAILURE; STENT FRACTURE; STENT THROMBOSIS; SUPERFICIAL FEMORAL ARTERY; ULTRASOUND;

AGED; ANGIOPLASTY; ARTERIAL OCCLUSIVE DISEASES; BICYCLING; CONSTRICTION, PATHOLOGIC; DRUG RESISTANCE; EXERCISE; FEMORAL ARTERY; HUMANS; MALE; PLATELET AGGREGATION INHIBITORS; PLATELET FUNCTION TESTS; PROSTHESIS DESIGN; PROSTHESIS FAILURE; RISK FACTORS; STENTS; THROMBOLYTIC THERAPY; THROMBOSIS; TICLOPIDINE; TREATMENT OUTCOME;

EID: 84858588015     PISSN: 03011526     EISSN: None     Source Type: Journal    
DOI: 10.1024/0301-1526/a000177     Document Type: Article

References (46)

1. Aleil B, Ravanat C, Cazenave JP, Rochoux G, Heitz A, Gachet C. Flow cytometric analysis of intraplatelet VASP phosphorylation for the detection of clopidogrel resistance in patients with ischemic cardiovascular diseases. J Thromb Haemost 2005; 1: 85-92.
2. Allie D, Herbert C, Walker C. Nitinol stent fractures in the SFA. Endovasc Today 2004; 3: 22-34.
3. Andreotti F, Lanza G, Sciahbai A, Fischetti D, Sestito A, De Cristofaro R, Maseri Al. Low-grade exercise enhances platelet aggregability in patients with obstructive coronary disease independently of myocar-dial ischemia. Am J Cardiol 2001; 87: 16-20.
4. Angiolillo DJ, Saucedo JF, De Raad R, Frelinger AL, Gurbel PA, Costigan TM, Jakubowski JA, Ojeh CK,Effron MB, for the SWAP Investigators. Increased platelet inhibition after switching from maintenanceclopidogrel to prasugrel in patients with acute coronary syndromes. J Am Coll Cardiol 2010; 56: 1017-23.
5. Ansel GM, Lumsden AB. Evolving modalities for femoropopliteal in terventions. J Endovasc Ther 2009; 16[Suppl II]: 1182-1197.
6. Chakravarty T, White AJ, Buch M, Naik H, Doctor N, Schapira J, Kar S, Forrester JS, Weiss RE, Makkar R. Meta-analysis of incidence, clinical characteristics and implication of stent fracture. Am J Cardiol 2010; 106: 1075-80.
7. Chen YW, Chen JK, Wnag JS. Strenuous exercise promotes shear-induced thrombin generation by increasing the shedding of procoagulant microparticles from platelets. Thromb Haemost 2010; 104: 293-301.
8. Chua S, Hung H. Renal artery stent fracture with refractory hyperten sion: a case report and review of the literature. Cathet Cardiovasc Interv 2009; 74: 37-42.
9. Duda SH, Bosiers, M, Lammer J, Scheinert D, Zeller T, Tielbeek A, Anderson J, Wiesinger B, Tepe G, Lansky A, Mudde C, Tielemans H, Beregi JP. Sirolimus-evluting versus bare nitinol stent for obstructive superficial femoral artery disease: the SIROCCO II trial. J Vasc Interv Radiol 2005; 16: 331-8.
10. Gulmez O, Yildirir A, Bal U, Konas ND, Aydinalp A, Demir O, Atar I, Ertan C, Ozin B, Muderrisoglu H. Assessment of biochemical aspirin resistance at rest and immediately after exercise testing. Blood Coagul Fibrinolysis 2007; 18: 9-13.
11. Higashiura W, Kubota Y, Sakaguchi S, Kurumatani N, Nakamae M, Nishimine K, Kichikawa K. Preva lence, factors, and clinical impact of selfexpanding stent fractures following iliac artery stenting. J Vasc Surg 2009; 49: 645-52.
12. Klepczyk L, Keeling WB, Stone PA, Shames ML. Superior mesenteric artery stent fracture producing stenosis and recurrent chronic mesenteric ischemia: case report. Vasc Endovascular Surg 2008; 42: 79-81.
13. Hirsch AT, Haskal ZJ, Hertzer NR, Bakal CW, Creager MA, Halperin JL, Hiratzka LF, Murphy WR, Olin JW, Puschett JB, Rosenfield KA, Sacks D, Stanley JC, Taylor LM Jr, White CJ, White J, White RA, Antman EM, Smith SC Jr, Adams CD, Anderson JL, Faxon DP, Fuster V, Gibbons RJ, Halperin JL, Hiratzka LF, Hunt SA,Jacobs AK, Nishimura R, Ornato JP, Page RL, Riegel B. ACC/AHA 2005 guidelines for the management of patients with peripheral arterial disease [lower extremity, renal, mesenteric, and abdominal aortic]: executive summary a collaborative report from the American Association for Vascular Surgery/Society for Vascular Surgery, Society for Cardiovascular Angiography and Interventions, Society for Vascular Medicine and Biology, Society of Interventional Radiology, and the ACC/AHA Task Force on Practice Guidelines [Writing Committee to Develop Guidelines for the Manage ment of Patients With Peripheral Arterial Disease] endorsed by the American Association of Cardio-vascular and Pulmonary Rehabili-tation; National Heart, Lung, and Blood Institute; Society for Vascular Nursing; Trans-Atlantic Inter-Society Consensus; and Vascular Disease Foundation. J Am Coll Cardiol 2006; 47: 1239-312.
14. Hochholzer W, Wiviott SD, Antman EM, Contant CF, Guo J, Giugliano RP, Dalby AJ, Montalescot G, Braunwald E. Predictors of bleeding and time dependence of association of bleeding with mortality insights from the trial to assess improvement in therapeutic outcomes by opti-mizing platelet inhibition with prasugrel-thrombolysis in myocardial infarction 38 [TRITON-TIMI 38]. Circulation 2011; 123: 2681-2689.
15. Iida O, Nato S, Uematsu M, Morozumi T, Kotani J, Awata M, Onishi T, Ito N, Sera F, Minamiguchi H, Akahori H, Nagata S. Effect of exercise on frequency of stent fracture in the superficial femoral artery. Am J Cardiol 2006; 98: 272-4.
16. Jaff M, Dake M, Pompa J, Ansel G,Yoder T. Standardized evaluation and reporting of stent fractures in clinical trials of noncoronary devices. Cathet Cardiovasc Interv 2007; 70: 460-2.
17. Kedora J, Hohmann S, Garrett W, Munschaur C, Theune B, Gable D. Randomized comparison of percutaneous Viabahn stent grafts vs prosthetic femoral-popliteal bypass in the treatment of superficial femoral arterial occlusive disease. J Vasc Surg 2007; 45: 10-6.
18. Krankenberg H, Schluter M, Steinkamp HJ, Burgelin K, Scheinert D, Schulte KL, Minar E, Peeters P, Bosiers M, Tepe G, Reimers B, Mahler F, Tubler T, Zeller T. Nitinol stent implantation versus percuta-neous transluminal angioplasty in superficial femoral artery lesions up to 10 cm in length: the femoral artery stenting trial [FAST]. Circulation 2007; 116: 285-92.
19. Ling AJ, Mwipatayi P, Gandhi T, Sieunarine K. Stenting for carotid artery stenosis: fractures, prosposed etiology and the need for surveil-lance. J Vasc Surg 2008; 47: 1220-6.
20. Linnemann B, Schwonberg J, Mani H, Prochnow S, Lindhoff-Last E. Standardization of light transmit-tance aggregometry for monitoring antiplatelet therapy: an adjustment for platelet count is not necessary. J Thromb Haemost 2008; 6: 677-83.
21. Linnemann B, Schwonberg J, Toennes SW, Mani H, Lindhoff-Last E. Variability of residual platelet function despite clopidogrel treat-ment in patients with peripheral arterial occlusive disease. Athero-sclerosis 2010; 209: 504-9.
22. Michelson AD. Methods for the measurement of platelet function. Am J Cardiol 2009; 103[3 Suppl]: 20A-26A.
23. Nikanorov A, Smouse HB, Osman K, Bialas M, Shrivastava S, Schwartz LB. Fracture of self-expanding nitinol stents stressed in vitro under simulated intravascular conditions. J Vasc Surg 2008; 48: 435-40.
24. Norgren L, Hiatt WR, Dormandy JA, Nehler MR, Harris KA, Fowkes FG, Bell K, Caporusso J, Durand-Zaleski I, Komori K, Lammer J, Liapis C, Novo S, Razavi M, Robbs J, Schaper N, Shigematsu H, Sapoval M, White C, White J, Clement D, Creager M, Jaff M, Mohler E, Rutherford RB, Sheehan P, Sillesen H, Rosenfield K. Inter-society consensus for the management of peripheral arterial disease. Eur J Vasc Endovasc Surg 2007; 33 Suppl 1: S1-S75.
25. Ormezzano O, Polack B, Vanzetto G, Sahnoun M, Machecourt J. Platelet hyperactivity during exercise leading to iterative coronary stent thrombosis: clinical implications.J Thromb Thrombolysis 2010; 30: 105-8.
26. Ouriel K, Shortell CK, De-Weese JA, Green RM, Francis CW, Azodo MV, Gutierrez OH, Manzione JV, Cox C, Marder VJ. A comparison of throm-bolytic therapy with operative revas-cularization in the initial treatment of acute peripheral arterial ischemia. J Vasc Surg 1994; 19: 1021-30.
27. Ouriel K, Veith FJ, Sasahara AA. A comparison of recombinant urokinase with vascular surgery as initialtreatment for acute arterial occlusion of the legs. Thrombolysis or Peripheral Arterial Surgery [TOPAS] Investigators. N Engl J Med 1998;16: 1105-11.
28. Pamukcu B, Oflaz H, Acar RD, Umman S, Koylan N, Umman B, Nisanci Y. The role of exercise on platelet aggregation in patients with stable coronary artery disease: exercise induces aspirin resistant platelet activation. J Thromb Thrombolysis 2005; 20: 17-22.
29. Perneby C, Wallén NH, Hu H, Li N, Hjemdahl P. Prothromboticresponses to exercise are little influenced by clopidogrel treatment. Thromb Res 2004; 114: 235-43.
30. Perneby C, Wallén NH, HofmanBang C, Tornvall P, Ivert T, Li N, Hjemdahl P. Effect of clopidogrel treatment on stress-induced platelet activation and myocardial ischemia in aspirin-treated patients with stable coronary artery disease. Thromb Haemost 2007; 98: 1316-22.
31. Phipp LH, Scott DJ, Kessel D, Robertson I. Subclavian stents and stent grafts: cause for concern? J Endovasc Surg 1999; 6: 223-6.
32. Rits J, van Herwaarden JA, Jahrome AK, Krievins D, Moll FL. The in-cidence of arterial stent fractures with exclusison of coronary, aortic, and non-arterial settings. Eur J Vasc Endovasc Surg 2008; 36: 339-45.
33. Robertson SW, Jessup DB, Boero IJ, Cheng CP. Right renal artery in vivo stent fracture. J Vasc Interv Radiol 2008; 19: 439-42.
34. Sabeti S, Mlekusch W, Amighi J, Minar E, Schillinger M. Primary patency of long-segment self-expanding nitinol stents in the emoropopliteal arteries. J Endovasc Ther 2005; 12: 6-12.
35. Saxon RR, Dake MD, Volgelzang RL, Katzen BT, Becker GJ. Randomized, multicenter study comparing expanded polytetrafluoroethylene-covered endoprosthesis placement with percutaneous transluminal angioplasty in the treatment of superficial femoral artery occlusive disease. J Vasc Interv Radiol 2008; 19: 823-32.
36. Scheinert D, Scheinert S, Sax J, Piorkowski C, Braunlich S, Ulrich M, Biamino G, Schmidt A. Prevalence and clinical impact of stent fractures after femoropopliteal stenting. J Am Coll Cardiol 2005; 45: 312-5.
37. Schillinger M, Sabeti S, Loewe C, Dick P, Amighi J, Mlekusch W, Schlager O, Cejna M, Lammer J, Minar E. Balloon angioplasty versus implantation of nitinol stents in the superficial femoral artery. N Engl J Med 2006; 354: 1879-88.
38. Sfyroeras GS, Koutsiaris A, Karathanos C, Giannakopoulos A, Giannoukas AD. Clinical relevance and treatment of carotid stent fractures. J Vasc Surg 2010; 51: 1280-5.
39. Simsek Z, Arslan S, Gundogdu F. Late stent thrombosis associated with heavy exercise. Tex Heart J 2009; 36: 154-7.
40. Tsutsumi M, Kazekawa K, Onizuka M, Kodama T, Matsubara S, Aikawa H, Iko M, Nii K, Etou H, Tanaka A. Stent fracture in revascularization for symptomatic ostial vertebral artery stenosis. Neuroradiology 2007; 49: 253-7.
41. Wang JS, Li YS, Chen JC, Chen YW. Effects of exercise training and decontitioning on platelet aggregation induced by alternating shear stress in men. Arterioscler Thromb Vasc Biol 2005; 25: 454-60.
42. Weaver FA, Comerota AJ, Young blood M, Froehlich J, Hosking JD, Papnicolaou G. Surgical revascularization versus thrombolysis for nonembolic lower extremity native artery occlusions: results of a prospective randomized trial. The STILE Investigators. Surgery versus Throm-bolysis for Ischemia of the Lower Ex-tremity. J Vasc Surg 1996; 4: 513-23.
43. Wolf Z, Mani H, Lindhoff-Last E. Stellenwert der Thrombozytenfunk-tionsdiagnostik. Internist 2009; 51: 1095-1108.
44. Zeller T. Current state of endovas-cular treatment of femoro-popliteal artery disease. Vascular Medicine 2007; 12: 223-34.
45. Zeller T, Tepe G. Treatment of acute limb ischemia with focus on endo-vascular techniques. VASA 2009; 38: 123-33.
46. Zwart B, van Kerkvoorde TC, van Werkum JW, Breet NJ, ten Berg JM van't Hof AW. Vigorous exercise as a triggering mechanism for late stent thrombosis: a description of three cases. Platelets 2010; 21: 72-76.